Opendata, web and dolomites
H2020 projects about "oncology"
The page lists 132 projects related to the topic "oncology".
| # | |||
|---|---|---|---|
| 1 | SOUND | Statistical multi-Omics UNDerstanding of Patient Samples | 2015 |
| 2 | MedBioinformatics | Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics) | 2015 |
| 3 | FORECEE | Female cancer prediction using cervical omics to individualise screening and prevention | 2015 |
| 4 | AdapTT | Real time therapy planning for Thermal based therapy modalities in oncology care. | 2015 |
| 5 | Biorapid | Rapid Bioprocess Development | 2015 |
| 6 | PRISAR | Preclinical Intra-Operative Image-Guided Surgery and Post-Operative Radiotherapy of Tumours | 2015 |
| 7 | InSPECT | Integrated Spectrometers for Spectral Tissue Sensing | 2015 |
| 8 | BIOLOCHANICS | Localization in biomechanics and mechanobiology of aneurysms: Towards personalized medicine | 2015 |
| 9 | APOBEC | Enzymatic DNA deamination and the immunity/cancer balance | 2015 |
| 10 | MED1C | MED1C : Video Management in Medical practice | 2015 |
| 11 | HUMICE | AXENIS Humanized Mice – Innovation towards industrial scale-up | 2015 |
| 12 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 13 | MultiDiag | Rapid, cost-effective, multiplex point of care diagnostic immunoassay system | 2015 |
| 14 | LEONID | Lung cancEr fusiOn geNes: a new dIagnostic Device | 2015 |
| 15 | OMA | Optimization of Medical Accelerators | 2016 |
| 16 | GlyCoCan | Exploiting Glycosylation of Colorectal Cancer for the development of improved diagnostics and therapeutics | 2015 |
| 17 | ULTIMA | ULTrafast Imaging sensor for Medical Applications | 2015 |
| 18 | FrEBT | Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL Ltd. competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device | 2015 |
| 19 | EPOCH28 | Epigenetic Profiling of Chemotherapy Efficacy | 2015 |
| 20 | BIOVALID | Clinical validation of the DiviTum assay in two high profile clinical studies in Europe | 2015 |
| 21 | RCC-TEST | A breakthrough in Renal Cell Carcinoma: Personalized RCC-Test | 2016 |
| 22 | REPROGRAM | Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases | 2016 |
| 23 | MIB | Multi-modal, Endoscopic Biophotonic Imaging of Bladder Cancer for Point-of-Care Diagnosis | 2016 |
| 24 | STREAM | Strategies towards Excellence in Immuno-Oncology | 2016 |
| 25 | MAINTRAC-Auto | MAINTRAC-Auto: Automatization and validation of a liquid biopsy assay “Maintrac-AUTO CTC-analyser” for predictive real time monitoring and success control of solid tumor cancer therapy | 2016 |
| 26 | LATE-STAGE | Palladium catalyzed C(sp3)‒H late-stage diversification of biologically active molecules | 2016 |
| 27 | THERAGEL | Development of a chemotherapeutic gel for glioblastoma multiforme treatment | 2016 |
| 28 | Wnt and CRC | Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors | 2017 |
| 29 | PET3D | PET Imaging in Drug Design and Development | 2016 |
| 30 | iCARE | MobIle health-Care system for monitoring toxicity and symptoms in cAncer patients ReceivingdiseasE-oriented therapy | 2016 |
| 31 | OWISE4EU | OWise for Europe - A feasibility study of a pan-European mobile app providing people with cancer with useful tools and treatment information in one easily accessible place. | 2016 |
| 32 | JEM Phase 1 | JEM: The world safest subcutaneous, enclosed, biocompatible implantable device, attached directly to a AV fistula or graft or vein, for chronic disease patients in need of repetitive vascular access | 2016 |
| 33 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 34 | PERMIDES | Personsalised Medicine Innovation through Digital Enterprise Solutions | 2016 |
| 35 | NO-META | Feasibility study of a NOvel METAbolic liquid biopsy for cancer therapy monitoring | 2016 |
| 36 | TransPot | Translational Research Network in Prostate Cancer | 2017 |
| 37 | DEIS | Dependability Engineering Innovation for CPS - DEIS | 2017 |
| 38 | TiMaScan | Recirculated tissue macrophages (TiMa) in blood: Novel approach to early diagnosis and treatment monitoring in oncology | 2016 |
| 39 | BITCAT | Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy | 2017 |
| 40 | HYPERTRANS | HYPERTRANS: Transport of hyperpolarized substrates for metabolic MR imaging | 2016 |
| 41 | 3D NEONET | Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics | 2017 |
| 42 | MIMESIS | A novel systems biology approach to develop preclinical assets from innovative drug discovery starting points inspired by viruses | 2016 |
| 43 | HYPOXIMMUNO | Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia | 2016 |
| 44 | iGBMavatars | Glioblastoma Subtype Avatar models for Target Discovery and Biology | 2017 |
| 45 | MECHANO-CONTROL | Mechanical control of biological function | 2017 |
| 46 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
| 47 | HISTO-MRI | IN SITU IMAGING OF LIVING TISSUES WITH CELLULAR SPATIAL RESOLUTION | 2017 |
| 48 | PDClungSME1 | A therapeutic vaccine candidate for lung cancer based on an exclusive cell line of Plasmacytoid Dendritic Cells (PDC*line) | 2016 |
| 49 | HapticCell | Haptic micromanipulation system for low cost autonomous microinjection tasks | 2017 |
| 50 | RELEASE | Nanofiber based drug delivery for surgical therapy of adult and paediatric solid tumours | 2017 |
| 51 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 52 | 3DPD | PhD position in commercial environment: cancer immunotherapy drug screening in 3D | 2017 |
| 53 | CMI2T IA | Harmless Clostridium bacteria as a highly targeted, continuous delivery system for immunomodulatory anti-cancer drugs | 2017 |
| 54 | Monomark | A comparative clinical study of a stool-based versus a blood-based screening test for earlydetection of CRC | 2017 |
| 55 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 56 | QUSMI | Translating quantum sensing into cost-effective molecular imaging | 2017 |
| 57 | CanFaster | The Translational Cancer Faster Forward doctoral programme – CanFaster | 2017 |
| 58 | NEST | Nanoengineering of radioactive seeds for cancer therapy and diagnosis | 2017 |
| 59 | TIGITtherapy | TIGIT therapy for cancer treatment | 2017 |
| 60 | SIRMIO | Small animal proton Irradiator for Research in Molecular Image-guided radiation-Oncology | 2017 |
| 61 | BigData Heart | Big Data 4 Better Hearts - Sofia ref.: 116074 | 2017 |
| 62 | NanoMAPs | High performance algorithms for high precision GPS and cloud solutions for super resolution microscopy | 2017 |
| 63 | Photoclin | Advanced clinical photoacoustic imaging systems based on optical microresonator detection | 2017 |
| 64 | REACT | Optimising Radiomics for MRI-based personalised cancer treatment | 2017 |
| 65 | CuHypMECH | New Nuclear Medicine Imaging Radiotracer 64Cu(II) for diagnosing Hypoxia Conditions Based on the Cellular Copper Cycle | 2017 |
| 66 | COSMIC | COmbatting disorders of adaptive immunity with Systems MedICine | 2018 |
| 67 | PREDICT | A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology | 2017 |
| 68 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 69 | CfC | Carrier for Cure: tailored combination drug delivery solutions for oncology | 2017 |
| 70 | BOUNCE | Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE Back | 2017 |
| 71 | EDIReX | EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts | 2018 |
| 72 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 73 | ELIMINATE | Development of strategies to eliminate cancer cells from the bone marrow | 2018 |
| 74 | OncoSeq | OncoSeq: an innovative single-cell system for immunomonitoring | 2017 |
| 75 | OmnImmune | Manufacturing and testing of an allogeneic gamma delta T cell therapy for the treatment of cancer | 2017 |
| 76 | CHROMABOLISM | Chromatin-localized central metabolism regulating gene expression and cell identity | 2018 |
| 77 | DETRIMODE | DEgradation TRIggered by MOdular DEsign | 2018 |
| 78 | PORTAL | Personalized oncology for refractory and relapsed lymphoma using humanized patient derived othotopic xenografts (ImmunePDOX) | 2018 |
| 79 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 80 | HOPE | Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 | 2018 |
| 81 | ONCOTICS | Probiotics for the Oncological Patients | 2018 |
| 82 | HemoScreen | Point-of-care hematology analyser based on visco-elastic focusing, digital imaging, image processing and machine learning | 2018 |
| 83 | TETHIS-SBS-CTC | TETHIS-SBS-CTC: An innovative diagnostic testing platform to identify and characterize circulating tumour cells (CTCs) in blood samples. | 2018 |
| 84 | PaSION | A longitudinal assessment of treatment experience, symptoms and potential associations with biomarkers in cancer patients undergoing immune checkpoint inhibitor therapy | 2018 |
| 85 | ElectroPros | Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments. | 2019 |
| 86 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 87 | BiopSense | Proof of concept and pre-commercialisation of personalised liquid biopsies in cancer therapy | 2018 |
| 88 | I-DireCT | Immune DIREcted and Cancer-selective immunoTherapy | 2019 |
| 89 | pHioniC | pH and Ion Transport in Pancreatic Cancer | 2018 |
| 90 | NextGen IO | Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology | 2019 |
| 91 | PRIMAGE | PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers | 2018 |
| 92 | CONQR | Translation and Commercialization of a QSOX1-inhibitory Antibody Targeting the Tumor Microenvironment in Breast Cancer | 2018 |
| 93 | TUMOURPRINT | High Throughput Bioprinting of Tumour Models for Drug Development and Oncology Research | 2018 |
| 94 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
| 95 | DaPhNIs | Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development | 2019 |
| 96 | IVD4Sepsis | Novel ultrasensitive detection device for early Sepsis diagnosis | 2019 |
| 97 | GLADIATOR | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | 2019 |
| 98 | ViroPedTher | Oncolytic viruses for the treatment of pediatric brain tumors: An integrated clinical and lab approach | 2019 |
| 99 | PROTONMBRT | Spatial fractionation of the dose in proton therapy: a novel therapeutic approach | 2019 |
| 100 | MP-101 | a novel drug for prevention and treatment peripheral neuropathy symptoms | 2019 |
| 101 | Cluster-Buster | Development of small molecule inhibitors of circulating tumor cell clusters | 2019 |
| 102 | EUCANCan | EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. | 2019 |
| 103 | Need2immune | Personalized liposomal cancer vaccines within days by rapid formulation screening | 2019 |
| 104 | IMMUcan | Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts | 2019 |
| 105 | HoloStain | Imaging flow cytometry using holographic virtual staining | 2019 |
| 106 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 107 | MIRACLE | Metabolic Imaging with RF Antennas to predict Chemotherapy Efficacy | 2019 |
| 108 | HARMONIC | Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs | 2019 |
| 109 | SCANRESIST | Reversal of anti-cancer drug resistance | 2019 |
| 110 | SIMCARE | SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment | 2019 |
| 111 | SPLITVAC | Harnessing the innate and adaptive immune system with targeted neoantigen based cancer vaccines | 2019 |
| 112 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 113 | TOPAS | Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies | 2019 |
| 114 | Chaperon | ERA Chair Position for Excellent Research in Oncology | 2019 |
| 115 | IMMUNOTRAP | Diagnosis test for immuno-oncology therapies. | 2019 |
| 116 | BIOXPLOR | BioXplor’s AI/Cognitive Software Platform accelerates and greatly reduces the cost of discovery research and clinical trials, with a primary focus on rare and inflammatory diseases data. | 2019 |
| 117 | AntiHelix | DNA helicases in genome maintenance: from molecular and cellular mechanisms to specific inhibitors as potential drugs | 2019 |
| 118 | INSPIRE | INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition. | 2020 |
| 119 | WAVESCOPE | Wavefront shaping system for nonlinear fiber-based microscopy and endoscopy | 2019 |
| 120 | CanFaster-Postdoc | The Translational Cancer Faster Forward postdoctoral programme – CanFaster-ER | 2020 |
| 121 | SPECIPHIC | Label-free quantitative nanoscopy for molecular specific identification at depth in pristine living biological tissues | 2020 |
| 122 | BioTrace | World's First Real-Time Monitoring System for Ablation Procedures | 2019 |
| 123 | TrojanDC | TrojanDC | 2019 |
| 124 | MEISi | Druggable Small Molecule Inhibitor of MEIS Proteins | 2019 |
| 125 | ICE_PACK | Polymer Materials for Cryogenic Storage and Distribution of Biologics | 2020 |
| 126 | NIMBUS4CIP | Effective management of pregnant cancer patients through a cloud-based integrative and highly specialized advisory board platform | 2020 |
| 127 | TACT | Targeted Anti-Cancer Therapies | 2020 |
| 128 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
| 129 | METABONE | A new approach of metastatic bone fracture prediction using a patient-specific model including metastatic tissue, daily-life activities and local failure criteria | 2020 |
| 130 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 131 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 132 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |